Skip to main content

Search This Blog

Prostate Cancer

Posts

Tumor biomarkers for diagnosis, prognosis and targeted therapy | Signal Transduction and Targeted Therapy

Get link
Facebook
X
Pinterest
Email
Other Apps

- June 08, 2026

Invalid Access Key! Invalid Access Key!

Prostate Cancer | Annals of Internal Medicine

Get link
Facebook
X
Pinterest
Email
Other Apps

- June 07, 2026

This summary is not available. Please click here to view the post.

Tumor biomarkers for diagnosis, prognosis and targeted therapy | Signal Transduction and Targeted Therapy

Get link
Facebook
X
Pinterest
Email
Other Apps

- June 07, 2026

Invalid Access Key! Invalid Access Key!

A Patient’s Guide to Breast Cancer

Get link
Facebook
X
Pinterest
Email
Other Apps

- June 06, 2026

Invalid Access Key! Invalid Access Key!

Male Breast Cancer: Symptoms, Causes and Treatment

Get link
Facebook
X
Pinterest
Email
Other Apps

- June 06, 2026

Invalid Access Key! Invalid Access Key!

Treatment Path for HR+/HER2- mBC

Get link
Facebook
X
Pinterest
Email
Other Apps

- June 06, 2026

Invalid Access Key! Invalid Access Key!

Can Your Cancer Treatment Be Hazardous to Others?

Get link
Facebook
X
Pinterest
Email
Other Apps

- June 05, 2026

Invalid Access Key! Invalid Access Key!

Powered by Blogger

Theme images by billnoll

Popular Posts

Expert Discusses Data From First Positive Trial for PARP Inhibitor in Prostate Cancer - Targeted Oncology

- November 05, 2019

Alan Bryce, MD PARP inhibition with olaparib (Lynparza) improved radiographic progression-free survival (rPFS) in heavily pretreated patients with metastatic castration-resistant prostate cancer (mCRPC) who had alterations in homologous recombination repair (HRR) genes, according to findings from the phase III PROfound trial presented at the 2019 ESMO Congress. This was the first positive randomized phase III trial reported evaluating a PARP inhibitor in men with mCRPC. The PROfound trial enrolled patients to 2 cohorts. In cohort A, 245 patients with BRCA1/2 or ATM alterations, markers of HRR, were randomized 2:1 to receive either olaparib (n = 162) or physician’s choice of abiraterone acetate (Zytiga) with prednisone or enzalutamide (Xtandi) (n = 83). In cohort B, 142 patients with alterations in the BARD1, BRIP1, CDK12, CHEK1/2, FANCL, PALB2, PPP2R2A, RAD51B/C/D , or RAD54L , all of which are associated with HRR indirectly, were also randomized 2:...

Penis cancer: How GPs mistake it for a sexual disease... but it can rob a man of his genitals - Daily Mail

- July 24, 2022

How GPs mistake penis cancer for a sexual disease... and it can rob a man of his genitals Hundreds of British men are forced to undergo life-altering surgery every year because doctors are missing the warning signs of penis cancer, experts say Disease, which affects around 700 men every year, can be cured if spotted early, with little impact on sex life Studies show half of all penis cancers are diagnosed at a late stage – when it's impossible to save the organ; a fifth of patients die from the disease By Ethan Ennals For The Mail On Sunday Published: 23:07 BST, 16 July 2022 | Updated: 23:07 BST, 16 July 2022 Hundreds of British men are forced to undergo life-altering surgery every year because doctors are missing the warning signs of penis cancer, experts say. The disease, which affects around 700 men every year, can be cured if spotted early, with little impact on sex life. But studies show ...

Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth Edition

- April 27, 2026

Invalid Access Key! Invalid Access Key!

How to detect colon cancer without a colonoscopy

- June 28, 2024

ketogenic diet and cancer :: Article Creator Could Diet Help Fight Brain Cancer? A British man who rejected the standard of care to treat his brain cancer has lived with the typically fatal glioblastoma tumor growing very slowly after adopting a ketogenic diet, providing a case study that researchers say reflects the benefits of using the body's own metabolism to fight this particularly aggressive cancer instead of chemo and radiation therapy. Published recently in the journal Frontiers in Nutrition, the report is the first evaluation of the use of ketogenic metabolic therapy (KMT) without chemo or radiation interventions, on a patient diagnosed with IDH1-mutant glioblastoma (GBM), said Boston College Professor of Biology Thomas Seyfried, a co-author of the report. Ketogenic therapy is a non-toxic nutritional approach, viewed as complementary or alternative, that uses a low-carbohydrate, high-fat diet to manage a range of cancers, including glio...

A Patient’s Guide to Breast Cancer

- June 06, 2026

Invalid Access Key! Invalid Access Key!

The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma

- April 27, 2026

Invalid Access Key! Invalid Access Key!

Cold and hot tumors: from molecular mechanisms to targeted therapy

Invalid Access Key! Invalid Access Key!

Better Cancer Survival Requires Better Health Insurance

- April 23, 2026

Invalid Access Key! Invalid Access Key!

Deep Learning With Radiomics for Disease Diagnosis and Treatment: Challenges and Potential

- April 26, 2026

Invalid Access Key! Invalid Access Key!

Prostate Cancer Upgrading on AS Linked to Perineural Invasion - Renal and Urology News

- July 25, 2022

Perineural invasion detected on biopsy in patients on active surveillance for low-risk prostate cancer is strongly associated with upgrading, investigators reported at the American Urological Association's 2022 annual meeting in New Orleans, Louisiana. Among 1969 patients in the 1995-2021 Johns Hopkins active surveillance (AS) registry, 1282 men were diagnosed with very low-risk and 687 men with low-risk disease. The median PSA level was 4.9 ng/mL. Over a median follow-up of 36 months on AS, 198 men (10.0%) displayed perineural invasion on at least 1 biopsy, including at diagnosis. "Perineural invasion — the presence of cancerous cells tracking along or around a nerve within the perineural space — is a well-established mechanism by which prostate cancer cells spread outside of the capsule," Claire M. de la Calle, MD, of Johns Hopkins University, Baltimore, Maryland explained in an interview. "It can be found in low-grade tumors and tumors that ...

Archive

June 202612
May 202631
April 202658
March 2026111
February 202677
January 202687
December 2025102
November 202572
October 202569
September 202598

Show more Show less

Labels

"cancer prostata" - Google News
"metastatic prostate cancer" - Google News
"prostate cancer causes" - Google News
"prostate cancer survival rate" - Google News
"prostate cancer treatment options" - Google News
"prostate cancer treatment" - Google News
"prostate cancer" - Google News
"prostatectomy" - Google News
"symptoms of prostate cancer in men" - Google News
cancer+prostata - Google News

Google News
IFTTT
metastatic prostate cancer
metastatic+prostate+cancer - Google News
prostate cancer
prostate cancer causes
prostate cancer survival rate
prostate cancer treatment
prostate cancer treatment options
prostate+cancer - Google News
prostate+cancer+causes - Google News
prostate+cancer+survival+rate - Google News
prostate+cancer+treatment - Google News
prostate+cancer+treatment+options - Google News
prostatectomy
prostatectomy - Google News
symptoms of prostate cancer in men
symptoms+of+prostate+cancer+in+men - Google News

Show more Show less